Source link : https://www.newshealth.biz/health-news/high-response-rates-with-gene-therapies-for-bcg-unresponsive-bladder-cancer/
SAN ANTONIO — More than 70% of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) achieved complete responses to a novel gene therapy, a small preliminary trial showed. Across a range of doses, 16 of 22 patients had a complete response to detalimogene voraplasmid (EG-70), including 15 at 3 months and 10 at 6 months. […]
Author : News Health
Publish date : 2024-05-04 22:03:21
Copyright for syndicated content belongs to the linked Source.